Key facts
- This page summarizes Robert W. Duggan's Form 4 filing for Summit Therapeutics Inc. (SMMT).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 01 May 2025, 18:09.
Robert W. Duggan - 29 Apr 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)
- Reporting relationship
- Co-Chief Executive Officer, Director, 10%+ Owner
- Issuer ticker
- SMMT
- Reported as of
- 29 Apr 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 May 2025, 18:09:55 UTC
- Prior SEC filing
- 09 Apr 2025
- Next SEC filing
- 02 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert W. Duggan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert W. Duggan filed Form 4 for Summit Therapeutics Inc. (SMMT) on 01 May 2025.
Change
- Previous filing in this sequence was filed on 09 Apr 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SMMT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +1,040,000
- Change %
- Price
- Shares after
- 1,040,000
- Date
- 29 Apr 2025
- Ownership
- By Spouse
- Underlying class
- Common Stock
- Underlying amount
- 1,040,000
- Exercise price
- $1.06
- Footnotes
- F1, F2, F3
SMMT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +400,000
- Change %
- Price
- Shares after
- 400,000
- Date
- 29 Apr 2025
- Ownership
- By Spouse
- Underlying class
- Common Stock
- Underlying amount
- 400,000
- Exercise price
- $1.29
- Footnotes
- F1, F2, F3
SMMT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +9,590,558
- Change %
- Price
- Shares after
- 9,590,558
- Date
- 29 Apr 2025
- Ownership
- By Spouse
- Underlying class
- Common Stock
- Underlying amount
- 9,590,558
- Exercise price
- $1.68
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025.
Footnote F2
Not applicable.
Footnote F3
The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.